Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan-Reference-Cited by-同舟云学术

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Published:2007-02 Issue:2 Volume:18 Page:317-323
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ohe Y.,Ohashi Y.,Kubota K.,Tamura T.,Nakagawa K.,Negoro S.,Nishiwaki Y.,Saijo N.,Ariyoshi Y.,Fukuoka M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/2/317/694598/mdl377.pdf

Reference32 articles.

1. The Editorial Board of the Cancer Statistics in Japan;Cancer Statistics in Japan 2005,2005

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-Small Cell Lung Cancer Collaborative Group;BMJ,1995

3. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer;Fukuoka;J Clin Oncol,1992

4. Paclitaxel (taxol);Rowinsky;N Engl J Med,1995

5. The taxoids: paclitaxel and docetaxel;Gelmon;Lancet,1994

Cited by 547 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real world results of locally advanced and metastatic lung cancer patients treated with platinum doublet chemotherapy in first line: Moroccan cohort;Translational Oncology;2024-09

2. Bazedoxifene Inhibits Cell Viability, Colony‐Forming Activity, and Cell Migration in Human Non–Small Cell Lung Cancer Cells and Improves the Treatment Efficacy of Paclitaxel and Gemcitabine;The Clinical Respiratory Journal;2024-08

3. Assessing the benefits and safety profile of incorporating poly ADP-ribose polymerase (PARP) inhibitors in the treatment of advanced lung cancer: a thorough systematic review and meta-analysis;Frontiers in Pharmacology;2024-06-21

4. Advances in monotherapy and combination therapy of S-1 for patients with advanced non-small cell lung cancer: a narrative review;Translational Cancer Research;2024-04

5. Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: non-clinical mouse model and phase I/IIa clinical study;Journal for ImmunoTherapy of Cancer;2024-03